FDA Announces Changes To ED Drug Labels

Law360, New York (October 19, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said Thursday that it has approved labeling changes for three popular erectile dysfunction drugs to better warn consumers about a possible risk of sudden hearing loss.

Pfizer Inc.'s Viagra, Eli Lilly & Co.'s Cialis, and Levitra, marketed jointly by Schering-Plough Corp. and GlaxoSmithKline Inc., already include warning labels for possible auditory side effects. The new labels will display a more prominent and specific warning about sudden hearing loss, and include new information for patients about what they should do if...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.